Clinical Trial Update: Comparison of Effects Between Conventional Dose and High Dose Escitalopram on Clinical Improvement in Patients With Obsessive-compulsive Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial comparing conventional-dose versus high-dose escitalopram for clinical improvement in obsessive-compulsive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Obsessive Compulsive Disorder | Phase 4 | Status: COMPLETED